A COMPARISON OF HIV RISK BEHAVIORS BETWEEN NEW AND LONG-TERM INJECTION DRUG USERS

The purpose of this study was to characterize the injection and sexual risk behaviors of a cohort of active drug injectors who have initiated injection within the past 4 years and to compare their behaviors with the risk behaviors of long-term injectors who have been injecting drugs since 1984. A stratified, network-based sample was used to recruit injection drug users from the streets in Miami-Dade, Florida. After screening for eligibility, which included a urine test to confirm current drug use, participants were administered a structured questionnaire that included basic demographic information, drug-use history, and HIV risk behavior practices. Both injector groups displayed a high level of HIV injection risk behavior. Although new initiates into injection demonstrated lower risk behavior than long-term injectors at the first injection episode, the current risk behavior between new and long-term injectors is similar. [Translations are provided in the International Abstracts Section of this issue.]

[1]  J. Inciardi,et al.  A Community Approach to AIDS Intervention: Exploring the Miami Outreach Project for Injecting Drug Users and Other High Risk Groups , 1991 .

[2]  C. Raymond.  Study of i.v. drug users and AIDS finds differing infection rate, risk behaviors. , 1988, JAMA.

[3]  B. Stepherson,et al.  Heroin sniffers: between two worlds. , 1988, Journal of psychoactive drugs.

[4]  A. Ball,et al.  HIV prevention among injecting drug users: responses in developing and transitional countries. , 1998, Public health reports.

[5]  D. Vlahov,et al.  Correlates of human immunodeficiency virus infection in intravenous drug users: are treatment-program samples misleading? , 1992, British journal of addiction.

[6]  M. Chesney,et al.  Effectiveness of psychosocial interventions in preventing HIV risk behaviour in injecting drug users , 1998, AIDS.

[7]  P. Selwyn,et al.  Risk factors for human immunodeficiency virus infection in intravenous drug users. , 1989, The New England journal of medicine.

[8]  D. Stull,et al.  Doing Team Ethnography , 1998 .

[9]  E. Trapido,et al.  Risk factors for HIV-1 seroconversion among injection drug users: a case-control study. , 1995, American journal of public health.

[10]  J. Inciardi,et al.  Drug sharing among intravenous drug users. , 1991, AIDS.

[11]  N. Flynn,et al.  Seroepidemiology of viral infections among intravenous drug users in northern California. , 1992, The Western journal of medicine.

[12]  A. Abdul-Quader,et al.  AIDS and the new drug injector , 1989, Nature.

[13]  S. Friedman,et al.  Working with heroin sniffers: clinical issues in preventing drug injection. , 1990, Journal of substance abuse treatment.

[14]  D. Vlahov,et al.  Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. , 1990, American journal of epidemiology.

[15]  R. Curtis,et al.  High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[16]  C. Mccoy,et al.  The prevalence and incidence of HIV among injection drug users: A five year panel study , 1999 .

[17]  Z. Sloboda,et al.  HIV risk factors among injecting drug users in five US cities , 1994, AIDS.

[18]  R. D'Aquila,et al.  Race/ethnicity as a risk factor for HIV-1 infection among Connecticut intravenous drug users. , 1989, Journal of acquired immune deficiency syndromes.

[19]  S. Friedman,et al.  Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users. , 1985, Annals of internal medicine.

[20]  M. Williams.  HIV seroprevalence among male IVDUs in Houston, Texas. , 1990, American journal of public health.

[21]  H. Ginzburg,et al.  HTLV-III exposure among drug users. , 1985, Cancer research.

[22]  S. Weiss,et al.  Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region. , 1986, JAMA.

[23]  W. El-Sadr,et al.  Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. , 1987, AIDS.

[24]  D. D. Des Jarlais,et al.  AIDS and the transition to illicit drug injection--results of a randomized trial prevention program. , 1992, British journal of addiction.

[25]  A. Neaigus,et al.  Social intervention against AIDS among injecting drug users. , 1992, British journal of addiction.

[26]  R. D’Aquila,et al.  Prevalence of HTLV-III infection among New Haven, Connecticut, parenteral drug abusers in 1982-1983. , 1986, The New England journal of medicine.

[27]  R. Stephens,et al.  Effects of an intervention program on AIDS-related drug and needle behavior among intravenous drug users. , 1991, American journal of public health.

[28]  A. Moss.  AIDS and intravenous drug use: the real heterosexual epidemic. , 1987, British medical journal.

[29]  C. Hartgers,et al.  Risk factors for the transition from noninjection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users. , 1994, American journal of epidemiology.

[30]  T. O'riordan,et al.  Cultural theory and risk: A review , 1999 .